ACI and ARB slow emphysema progression

Regular angiotensin-converting inhibitors (ACI) or angiotensin II receptor blockers (ARB) use to associated with a more than ten times reduction in the speed of emphysema progression.

Leave your comment


This site uses Akismet to reduce spam. Learn how your comment data is processed.

Notify of